AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
7.53
-0.20 (-2.59%)
At close: Nov 17, 2026, 4:00 PM EST
7.40
-0.13 (-1.73%)
After-hours: Nov 17, 2026, 7:30 PM EST
AdaptHealth Revenue
AdaptHealth had revenue of $745.65M in the quarter ending September 30, 2026, with 10.90% growth. This brings the company's total for the last twelve months to $3.15B, up 6.34% year-over-year. In the year 2025, AdaptHealth had annual revenue of $3.24B, down -0.49%. That makes AdaptHealth the 3,472nd largest company in the world by revenue and 976th in the United States.
Revenue (ttm)
$3.15B
Revenue Growth
+6.34%
P/S Ratio
0.29
Revenue / Employee
$315,291
Employees
10,900
Market Cap
1.01B
Revenue by Segment
- Sleep Health 1.38B 42.5%
- Respiratory Health 691.16M 21.3%
- Diabetes Health 592.41M 18.3%
- Wellness At Home 583.14M 18.0%
Fiscal year ended Dec 31, 2025 See the full AdaptHealth breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.24B | -16.12M | -0.49% |
| Dec 31, 2024 | 3.26B | 60.80M | 1.90% |
| Dec 31, 2023 | 3.20B | 229.58M | 7.73% |
| Dec 31, 2022 | 2.97B | 516.06M | 21.02% |
| Dec 31, 2021 | 2.45B | 1.40B | 132.35% |
| Dec 31, 2020 | 1.06B | 526.75M | 99.45% |
| Dec 31, 2019 | 529.64M | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | 192.56M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Integra LifeSciences Holdings | 1.66B |
| Alphatec Holdings | 839.72M |
| Bioventus | 585.64M |
| Artivion | 481.88M |
| PROCEPT BioRobotics | 352.31M |
| OrthoPediatrics | 264.14M |
| SI-BONE | 220.65M |
| Cytek Biosciences | 207.65M |
AHCO News
- 7 days ago - AdaptHealth Transcript: UBS Global Healthcare Conference - Transcripts
- 13 days ago - AdaptHealth Corp. to Participate in Upcoming Investor Conference - Business Wire
- 13 days ago - AdaptHealth price target lowered to $9 from $10 at UBS - TheFly
- 14 days ago - AdaptHealth Earnings Call Transcript: Q3 2026 - Transcripts
- 14 days ago - AdaptHealth Earnings release: Q3 2026 - Filings
- 14 days ago - AdaptHealth Slides: Q3 2026 - Filings
- 14 days ago - AdaptHealth Quarterly report: Q3 2026 - Filings
- 14 days ago - AdaptHealth reports Q3 EPS ($1.13) vs 17c last year - TheFly